|
業務類別
|
-- |
|
業務概覽
|
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases. |
| 公司地址
| Sant Ferran 74, Cornellà de Llobregat, Barcelona, ESP, 08940 |
| 電話號碼
| +34 935151313 |
| 傳真號碼
| +34 933774028 |
| 公司網頁
| http://www.oryzon.com |
| 員工數量
| 40 |
| Dr. Pierre Beaurang, PhD |
Independent Director |
27/02/2026 |
| Ms. Montserrat Vendrell Rius |
Independent Director |
27/02/2026 |
| Mr. Luis Sanchez Quintana |
Independent Director |
27/02/2026 |
| Mr. Carlos Manuel Buesa Arjol |
Chairman of the Board and Chief Executive Officer |
27/02/2026 |
| Dr. Manuel Oscar Lopez-Figueroa |
Lead Independent Director |
27/02/2026 |
| Dr. Konstantinos Alataris |
Independent Director |
27/02/2026 |
|
|
|
|
